Table 1

Inpatient treatment of migraine7

Therapeutic optionStrength of evidence
Subcutaneous sumatriptanStrong recommendation, moderate-quality evidence
Intravenous prochlorperazineStrong recommendation, high-quality evidence
Intravenous chlorpromazineWeak recommendation, moderate-quality evidence
Oral NSAIDsStrong recommendation, low-quality evidence
Intravenous lignocaineLow-quality evidence,5 14
Intravenous ketamineLow-quality evidence15
  • Given the lack of substantive evidence of current inpatient therapy, the significant potential side effect profile and health-economic cost both in prolonged hospital admission and representation there is an urgent need for new therapies.

  • NSAID, Non-steroidal anti-inflammatory drug.